Matches in Wikidata for { <http://www.wikidata.org/entity/Q66032936> ?p ?o ?g. }
Showing items 1 to 39 of
39
with 100 items per page.
- Q66032936 description "clinical trial" @default.
- Q66032936 description "ensayu clínicu" @default.
- Q66032936 description "klinisch onderzoek" @default.
- Q66032936 description "клінічне випробування" @default.
- Q66032936 name "2 Doses of an Approved Drug Being Studied for a New Indication for the Prevention of Postoperative Nausea and Vomiting (0869-091)" @default.
- Q66032936 name "2 Doses of an Approved Drug Being Studied for a New Indication for the Prevention of Postoperative Nausea and Vomiting" @default.
- Q66032936 type Item @default.
- Q66032936 label "2 Doses of an Approved Drug Being Studied for a New Indication for the Prevention of Postoperative Nausea and Vomiting (0869-091)" @default.
- Q66032936 label "2 Doses of an Approved Drug Being Studied for a New Indication for the Prevention of Postoperative Nausea and Vomiting" @default.
- Q66032936 prefLabel "2 Doses of an Approved Drug Being Studied for a New Indication for the Prevention of Postoperative Nausea and Vomiting (0869-091)" @default.
- Q66032936 prefLabel "2 Doses of an Approved Drug Being Studied for a New Indication for the Prevention of Postoperative Nausea and Vomiting" @default.
- Q66032936 P1050 Q66032936-0965AEE9-D8BC-4ACE-BF80-F9624E4A2FF9 @default.
- Q66032936 P1050 Q66032936-2E25C31F-BA26-4840-9A7F-7BA5E6C8269E @default.
- Q66032936 P1050 Q66032936-B3A331E7-A143-45CA-B25F-CDCD192264C4 @default.
- Q66032936 P1132 Q66032936-4CBE0B52-277C-4434-9B58-5724C2CA9BAA @default.
- Q66032936 P1476 Q66032936-5BB3EDFD-18E5-4684-84B2-2D60DCE05A0B @default.
- Q66032936 P2899 Q66032936-40DE0130-6117-44D1-BDBC-C3A6A8C11BF2 @default.
- Q66032936 P3098 Q66032936-51784DEC-5F1D-4564-AFB5-57A98A1FCC3A @default.
- Q66032936 P31 Q66032936-FF03822D-7B2B-4A78-8E49-54E1631F8075 @default.
- Q66032936 P4844 Q66032936-2B4818BC-BA40-4C76-B9FF-465573C6D7BE @default.
- Q66032936 P4844 Q66032936-414D2CA2-0185-42CC-B14F-0D57F721AB98 @default.
- Q66032936 P580 Q66032936-682F023A-E553-441D-B489-63BDEB899370 @default.
- Q66032936 P582 Q66032936-9BB8F3C4-30FC-4C3B-8F49-EF75342B3A30 @default.
- Q66032936 P6099 Q66032936-155C38AB-5A4F-4B5D-A298-A5F31662AAD9 @default.
- Q66032936 P8363 Q66032936-90C57A70-5692-4850-B630-FACE43C173F6 @default.
- Q66032936 P1050 Q127076 @default.
- Q66032936 P1050 Q1658731 @default.
- Q66032936 P1050 Q186889 @default.
- Q66032936 P1132 "+922" @default.
- Q66032936 P1476 "A Randomized, Double-Blind, Active Comparator-Controlled, Parallel-Group Study, Conducted Under In-House Blinding Conditions, to Examine the Safety, Tolerability, and Efficacy of 2 Doses of Aprepitant for the Prevention of Postoperative Nausea and Vomiting" @default.
- Q66032936 P2899 "+18" @default.
- Q66032936 P3098 "NCT00090246" @default.
- Q66032936 P31 Q30612 @default.
- Q66032936 P4844 Q410011 @default.
- Q66032936 P4844 Q5473324 @default.
- Q66032936 P580 "2004-05-13T00:00:00Z" @default.
- Q66032936 P582 "2005-04-06T00:00:00Z" @default.
- Q66032936 P6099 Q42824827 @default.
- Q66032936 P8363 Q78089383 @default.